UBS Group’s CytRx Corp CYTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,250
Closed -$21K 10161
2014
Q4
$21K Buy
+1,250
New +$19.5K ﹤0.01% 7645

Other funds holding CYTR

UBS Group's CYTR Position: Q2 2019 in Review

UBS Group sold out of CytRx Corp (CYTR) in Q2 2019, closing a stake of 2,389 shares — an estimated $2K sold.

UBS Group first reported a position in CYTR in Q4 2014 and held it in 18 quarters. The position peaked at $34K in Q2 2016. 5 funds tracked by Wall St. Rank hold CYTR as of Q2 2019.

  • UBS Group reported no remaining CytRx Corp position as of Q2 2019 after selling out during the quarter.
  • UBS Group sold 2,389 CytRx Corp shares in Q2 2019, an estimated $2K.
  • UBS Group first reported a position in CytRx Corp in Q4 2014 and held it in 18 quarters.
  • UBS Group's CytRx Corp position peaked at $34K in Q2 2016.
  • 5 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2019.

Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.